Physician profile
Timothy Husted
NPI 1598765158
$1,895.69
in general payments reported to CMS, 2019-2025
30 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $186 · 2021: $201 · 2022: $323 · 2023: $499 · 2024: $101 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796 · Consulting Fee: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.20 |
| Consulting Fee | $105.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $461.25 | 2020-2024 | Gattex, Eohilia |
| Medtronic, INC. | $198.49 | 2021-2025 | Surgipro Ll, Lapro-Clip, Eea |
| Intuitive Surgical, INC. | $185.58 | 2019-2025 | |
| Integra Lifesciences Corporation | $159.54 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $132.01 | 2023 | Phasix Mesh |
| Vioptix INC | $107.12 | 2022 | |
| Kerecis Limited | $98.76 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Ethicon US, LLC | $76.40 | 2025 | Vistaseal, Ethicon, Dermabond Prineo |
| Shire North American Group INC | $50.24 | 2019 | |
| Tela Bio, INC. | $36.87 | 2020 | |
| Hologic Sales and Service, LLC | $31.36 | 2023 | Coolseal Generator |
| Heron Therapeutics, INC. | $28.42 | 2021 | |
| Polarityte, INC. | $26.19 | 2019 | |
| Urgo Medical North America, LLC | $25.37 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Acera Surgical, INC. | $24.40 | 2023 | Restrata Wound Matrix |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21.06 | 2019 | |
| Checkpoint Surgical, INC | $20.87 | 2023 | Checkpoint Stimulators |
| Organogenesis INC. | $19.64 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.91 | 2019 | |
| Solventum Corporation | $18.15 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Celularity INC. | $18.00 | 2019 | |
| Baudax Bio INC. | $16.20 | 2021 | |
| Corcept Therapeutics | $16.07 | 2019 | |
| Covidien Lp | $16.07 | 2019 | |
| Braintree Laboratories, INC. | $15.75 | 2023 | Sutab |
| Acelrx Pharmaceuticals, INC. | $15.56 | 2019 | |
| Merck Sharp & Dohme LLC | $15.42 | 2019 | |
| Innocoll Pharmaceuticals Limited | $15.22 | 2021 | |
| Innovation Technologies INC | $15.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Husted listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.